Summary: The Centers for Medicare & Medicaid Services modified its sacral nerve stimulation for urinary incontinence coverage policy, with an effective date of May 15, 2026. Here's what billing teams need to do before that date.
CMS sacral nerve stimulation coverage policy changes affect urology, urogynecology, and colorectal surgery practices that bill Medicare for implantable neurostimulator procedures. The policy does not list specific CPT or HCPCS codes in the available data — but the clinical criteria, medical necessity standards, and coverage boundaries for this procedure have a long history of driving claim denials. Before May 15, 2026, your billing team needs to review documentation requirements, prior authorization workflows, and patient selection criteria against the updated policy. If your practice has significant Medicare volume for this procedure, loop in your compliance officer now.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Sacral Nerve Stimulation For Urinary Incontinence |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | May 15, 2026 |
| Impact Level | High |
| Specialties Affected | Urology, Urogynecology, Colorectal Surgery, Neurology, Pain Management |
| Key Action | Audit documentation and prior authorization workflows against the updated policy before May 15, 2026 |
CMS Sacral Nerve Stimulation Coverage Criteria and Medical Necessity Requirements 2026
Sacral nerve stimulation — also called sacral neuromodulation — involves surgically implanting a device that delivers electrical impulses to the sacral nerves to treat urinary incontinence, urinary urgency-frequency, and non-obstructive urinary retention. CMS has covered this procedure under Medicare for years, but the medical necessity criteria have always been narrow and heavily documentation-dependent.
The core issue with sacral nerve stimulation billing is the two-stage implant structure. Stage one is a percutaneous test stimulation or a staged trial. Stage two is the permanent implant. CMS requires that patients demonstrate meaningful clinical improvement during the trial phase before the permanent implant is covered. If your documentation doesn't capture that improvement clearly, you're looking at a claim denial on the permanent implant — and those denials are hard to overturn without airtight trial records.
Historically, CMS coverage policy for sacral nerve stimulation has required that patients fail conservative therapies first. That means documented trials of behavioral modification, pelvic floor exercises, and pharmacological treatment before a patient is eligible. "Documented" is doing a lot of work in that sentence — notes that say "patient tried medications" without specifics don't satisfy medical necessity under this coverage policy.
Prior authorization requirements for sacral nerve stimulation vary by Medicare Administrative Contractor. Some MACs have issued local coverage determinations that add criteria on top of CMS national policy. Check with your MAC before assuming the national policy is the only standard you need to meet.
Reimbursement for the permanent implant procedure is substantial, which is exactly why CMS scrutinizes these claims closely. The financial exposure from a denied permanent implant claim — or a recoupment after a post-payment audit — is significant. Your documentation has to be airtight at every step: the diagnosis, the failed conservative therapies, the trial results, and the implant decision.
CMS Sacral Nerve Stimulation Exclusions and Non-Covered Indications
CMS does not cover sacral nerve stimulation for all types of urinary incontinence. Stress urinary incontinence — the kind caused by physical activity, coughing, or sneezing — is not a covered indication. Coverage applies to urge incontinence, urgency-frequency syndrome, and non-obstructive urinary retention.
Patients with certain anatomical or neurological conditions may also fall outside coverage. Patients with complete spinal cord injuries, for example, have historically been excluded. Pregnancy is a contraindication. Patients who are poor surgical candidates due to comorbidities may not meet medical necessity criteria under this coverage policy.
The bilateral implant is another area where CMS draws a hard line. Bilateral sacral nerve stimulation is not a covered indication under Medicare. If you're billing for bilateral procedures, expect denial.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Urge urinary incontinence | Covered (when criteria met) | Not listed in policy data | Must fail conservative therapy; trial phase improvement required |
| Urgency-frequency syndrome | Covered (when criteria met) | Not listed in policy data | Same documentation requirements as urge incontinence |
| Non-obstructive urinary retention | Covered (when criteria met) | Not listed in policy data | Obstruction must be ruled out; trial phase required |
| Stress urinary incontinence | Not Covered | Not listed in policy data | Not a covered indication under CMS policy |
| Bilateral sacral nerve stimulation | Not Covered | Not listed in policy data | Only unilateral implant is covered |
| Patients with complete spinal cord injury | Not Covered | Not listed in policy data | Excluded population historically |
| Fecal incontinence (without urinary indication) | Not Covered / MAC-dependent | Not listed in policy data | Some MACs have separate local coverage determinations |
CMS Sacral Nerve Stimulation Billing Guidelines and Action Items 2026
| # | Action Item |
|---|---|
| 1 | Pull your MAC's local coverage determination before May 15, 2026. National CMS policy sets the floor, but your Medicare Administrative Contractor may have issued an LCD with stricter criteria or additional documentation requirements. If you don't know which MAC covers your region, find out now. Billing against national policy alone when your MAC has a more restrictive LCD is a fast path to denial. |
| 2 | Audit your stage-one trial documentation templates. The permanent implant reimbursement hinges on the trial. Your documentation must capture baseline voiding diary data, the specific improvement metrics during the trial, and the physician's explicit statement that the patient meets criteria for a permanent implant. Vague notes don't survive audit. If your templates don't force that documentation, fix them before the effective date. |
| 3 | Verify your prior authorization workflow includes MAC-specific requirements. Prior authorization for sacral nerve stimulation under Medicare is not uniformly required nationally, but many MACs do require it. Confirm with your specific MAC. If prior auth is required and you're not getting it consistently, you're generating uncompensated work and avoidable denials. |
| 4 | Review your ICD-10 diagnosis code selection for the procedure. The diagnosis codes on your claim need to match the covered indications. Stress urinary incontinence codes will generate automatic denials. Make sure your coders understand the distinction between urge incontinence, urgency-frequency, and stress incontinence — and that the physician's documentation supports the correct code before the claim goes out. |
| 5 | Build a pre-claim checklist for the permanent implant. Before billing for the stage-two permanent implant, confirm: (a) the trial documentation is complete and in the record, (b) the diagnosis code is a covered indication, (c) conservative therapy failure is documented with specifics, (d) the MAC's prior authorization is in hand if required, and (e) the device itself is documented as approved. A checklist reviewed before submission is faster than working a denial. |
| 6 | Flag high-volume providers for a documentation audit. If you have providers implanting a high volume of sacral nerve stimulators, run a retrospective audit of recent claims against the updated criteria. CMS and MACs use utilization patterns to target post-payment reviews. Getting ahead of that is much cheaper than responding to a recoupment demand. |
| 7 | Talk to your compliance officer if you're unsure how this modification applies to your patient mix. The change type is "modified" — meaning something in the criteria, coverage boundaries, or documentation requirements shifted. Until the full policy text is available, you're working with historical criteria. If your practice has significant exposure here, your compliance officer should review the updated policy text directly and compare it to your current workflows. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Sacral Nerve Stimulation Under This Policy
The policy data for this modification does not list specific CPT, HCPCS, or ICD-10 codes. Do not use this absence as a reason to delay your review.
Sacral nerve stimulation billing involves a well-established set of procedure codes that your billing team likely already uses. However, PayerPolicy does not fabricate code data that isn't present in the policy document itself. Pulling the actual code list from the updated CMS policy or your MAC's LCD is a required step in your pre-May 15 workflow.
What to Do Instead
Pull the current code list from two sources: the updated CMS policy directly at the source URL (https://app.payerpolicy.org/p/cms/249-v1) and your MAC's current LCD for sacral nerve stimulation. Cross-reference both against your charge master.
Sacral nerve stimulation billing has historically involved codes for the trial lead placement, the permanent lead placement, the implantable pulse generator, and related programming and follow-up services. Each of those code categories has its own coverage rules under Medicare. Your coding team should verify every code in your charge capture is still covered under the modified policy before the May 15, 2026 effective date.
If you find discrepancies between what you're currently billing and what the updated policy supports, escalate to your compliance officer before submitting claims under the new policy. Retroactive denials and recoupments on neurostimulator implants carry significant dollar exposure.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.